selected publications
- Clinical implications of drug-induced liver injury in early-phase oncology clinical trials. Cancer. 2020 Academic Article GET IT
-
Phase Ib Study of Enzalutamide with or Without Sorafenib in Patients with Advanced Hepatocellular Carcinoma.
The oncologist.
2020
Academic Article
GET IT
Times cited: 12 -
Genomic Methods Identify Homologous Recombination Deficiency in Pancreas Adenocarcinoma and Optimize Treatment Selection.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2020
Academic Article
GET IT
Times cited: 146 -
Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures.
Genome biology.
2016
Academic Article
GET IT
Times cited: 673 -
An Open-Label, Dose-Escalation Phase I Study of Anti-TYRP1 Monoclonal Antibody IMC-20D7S for Patients with Relapsed or Refractory Melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2016
Academic Article
GET IT
Times cited: 19 -
The New Era of Cancer Immunotherapy: Manipulating T-Cell Activity to Overcome Malignancy.
Advances in cancer research.
2015
Article
GET IT
Times cited: 31 -
Treatments for noncutaneous melanoma.
Hematology/oncology clinics of North America.
2014
Information Resource
GET IT
Times cited: 8